-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

Benzinga·10/12/2026 21:15:08
UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.